强生降低美国药价以换取关税减免 专家称对参保者节省有限

Group 1 - Johnson & Johnson (JNJ) experienced a 0.5% decline in early trading on Friday [1][2] - The company agreed to lower prices on certain drugs and join the TrumpRx.gov platform in exchange for tariff exemptions and a U.S. investment plan [1][2] - Experts believe that the savings for most insured patients will be limited [1][2]